The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Abbvie; AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche; Takeda
Lorlatinib for advanced ALK and ROS1+ non-small cell lung cancer (NSCLC): Efficacy and treatment sequences in the IFCT-1803 LORLATU expanded access program (EAP) cohort.
 
Simon Baldacci
Honoraria - Boehringer Ingelheim; MSD
Travel, Accommodations, Expenses - GlaxoSmithKline; Lilly; Pfizer; Roche
 
Virginie Avrillon
No Relationships to Disclose
 
Benjamin Besse
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); BeiGene (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Cristal Therapeutics (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Inivata (Inst); Ipsen (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Nektar (Inst); Onxeo (Inst); OSE Immunotherapeutics (Inst); Pfizer (Inst); PharmaMar (Inst); Roche/Genentech (Inst); Sanofi (Inst); SERVIER (Inst); Spectrum Pharmaceuticals (Inst); Takeda (Inst); Tiziana Therapeutics (Inst); Tolero Pharmaceuticals (Inst)
 
Bertrand Mennecier
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly; Pierre Fabre; Roche/Genentech; Vifor Pharma
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); MSD (Inst); novartis (Inst); Regeneron (Inst); Roche/Genentech (Inst)
Expert Testimony - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche
 
Michael Duruisseaux
No Relationships to Disclose
 
Julien Mazieres
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly/ImClone; MSD; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer; Roche
 
Renaud Descourt
Consulting or Advisory Role - Bristol-Myers Squibb; Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Helene Doubre
No Relationships to Disclose
 
Pascale Dubray-Longeras
Research Funding - MSD (Inst)
 
Jacques Cadranel
Honoraria - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche/Genentech
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Takeda
Research Funding - AstraZeneca/MedImmune (Inst); Novartis (Inst); Pfizer (Inst)
 
Denis Moro-Sibilot
Consulting or Advisory Role - Abbvie; Amgen; ARIAD; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Lilly/ImClone; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Sanofi; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly/ImClone; MSD Oncology; Pfizer; Roche/Genentech
 
Charles Ricordel
No Relationships to Disclose
 
Sigolène Galland-Girodet
No Relationships to Disclose
 
Isabelle Monnet
Travel, Accommodations, Expenses - MSD Oncology
 
Josiane Otto
No Relationships to Disclose
 
Sophie Schneider
No Relationships to Disclose
 
Pascale Missy
No Relationships to Disclose
 
Franck Morin
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Virginie Westeel
Honoraria - Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Roche; Takeda
Speakers' Bureau - Bristol-Myers Squibb; MSD; Roche
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Fresenius (Inst); Lilly (Inst); Merck (Inst); MSD (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche
 
Nicolas Girard
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Pharmamar; Roche; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology; Roche